Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Siemens Healthineers Dade™ Innovin™ PT Reagent (US)

For use in prothrombin time (PT) determinations and prothrombin time-based assays in citrated human plasma.

Supplier:  Siemens Healthineers 10873566

 View more versions of this product

Catalog No. 23-044-776


Explore all special offers
Add to Cart
This item is not returnable. View return policy

Description

Description

Dade™ Innovin™ Reagent is prepared from purified recombinant human tissue factor produced in E. coli combined with synthetic phospholipids, calcium, buffers, and stabilizers. The reagent contains minimal residual clotting factors, such as prothrombin and factors VII or X, for clear definition of factor deficiencies and steep factor assay curves. It is highly sensitive to extrinsic factor deficiencies and oral anticoagulant-treated patient plasma samples.

The sensitivity of the Dade™ Innovin™ Reagent is very similar to the WHO human brain reference thromboplastin. It is insensitive to therapeutic levels of heparin, which, in combination with its high sensitivity to coagulation factors, makes Dade™ Innovin™ ideal for monitoring oral anticoagulant therapy and differentiating abnormal plasmas, even in the mildly pathological range.

TRUSTED_SUSTAINABILITY
Specifications

Specifications

Hemostasis Reagent
Prothrombin Time (PT) Testing
10 x 4 mL
Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.